X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Press Statements

MEDICAL FAIR ASIA 2020 goes Digital with Online Convenience for Medical Sourcing Needs

Content Team by Content Team
24th September 2020
in Press Statements
MEDICAL FAIR ASIA 2020 goes Digital with Online Convenience for Medical Sourcing Needs

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Messe Düsseldorf Asia announced that the 13th edition of MEDICAL FAIR ASIA will take place as a digital edition from 9-18 December. MEDICAL FAIR ASIA Digital Edition will offer a purpose-built online B2B experience for manufacturers, suppliers, distributors and trade buyers from the medical and healthcare sector to conduct business on a secure sourcing platform.

The well-established medical and healthcare exhibition first started in 1997 has since grown to be one of the most recognised regional events for sourcing hospital, diagnostic, pharmaceutical, medical and rehabilitation equipment and supplies. This shift to a digital event is in response to the dynamic situation of the COVID-19 pandemic, where travel and physical restrictions are still in effect globally.

Moving from in-person interactions at a physical trade event to making virtual connections anywhere in the world, MEDICAL FAIR ASIA Digital Edition aims to deliver the onsite benefits of a trade fair but with all the convenience of an online experience.

Mr Gernot Ringling, Managing Director, Messe Düsseldorf Asia, said: “It is a new reality in these trying economic times and we continue to adjust how we do business in the face of new customer habits and digital trends. Taking care of our customers is a top priority, and in the absence of a physical exhibition this year, staying true to the MEDICAL FAIR ASIA brand, both exhibitors and visitors can be assured that the digital edition will be an effective platform connecting global sellers and quality buyers.”

“On the back of the COVID-19 pandemic, there are clear signals that indicate an acceleration of omni-channel selling, tech-enabled selling and e- commerce. We believe the digital edition is well timed in serving the current needs of the medical industry, as well as medium term needs as potential demand for elective and delayed essential procedures see resurgence,” added Mr Ringling.

More than 300 international companies are expected to participate at the digital edition. In addition, over 30 presentation and conference sessions will run concurrently – live and on-demand, with speakers from the Start-Up Podium and Wearable Technologies ASIA Conference.

Ms Daphne Yeo, Senior Project Manager, MEDICAL FAIR ASIA, Messe Düsseldorf Asia said: “We are excited to announce this digital edition and believe it will be a fresh experience for exhibitors and visitors to do business and remain connected via this new format. The live-streaming and video call features where exhibitors and visitors can interact face-to-face is as personal an encounter as is possible and coupled with the multi-language capabilities, we are confident it will be an effective business platform.”

Strategic sourcing online

MEDICAL FAIR ASIA Digital Edition will offer trade visitors focused and targeted sourcing opportunities – from medical products and devices, rehabilitative equipment and new technology, telemedicine, to pandemic management solutions.

The digital exhibition will allow companies to present their product offerings and services online, with live-streaming of product demonstrations, real- time interaction with buyers via one-to-one video meets and instant chats. On a user-friendly dashboard, both exhibitors and visitors can view suitable matches and personalised meeting suggestions based on their interests and profile through AI driven smart business matching. Trade visitors will also have access to a comprehensive technical presentation showcase throughout the exhibition.

Attendees to the concurrent line-up of activities will experience the full benefits of a live conference including presentations and Q&A sessions. Content will also be available on-demand for delegates based in different time zones.

Mr Darren Liao, Product Manager of Milli-Q Lab water Division, Merck Pte Ltd, said, “Joining the digital edition this year was a natural decision particularly with the challenging travel restrictions. We look forward to join the exhibition, so we can share our solutions to clinical, pharmaceutical and medical device companies and at the same time, contribute to the COVID diagnostic and related research.”

Commenting on the positive feedback from exhibitors on the move to a digital edition, Mr Ringling said that after an extended period of isolation, businesses are likely to have an appetite to get back on track as economic recovery begins and remains hopeful in playing a part to stimulate activity and investment in the B2B event space with the digital edition. “The visceral enthusiasm and our human need to interact and for personal encounters at exhibitions are irreplaceable and will result in recovery in time. We are optimistic and look forward to staging the physical exhibition at the next edition of the MEDICAL FAIR series which will take place next year in Bangkok,” he said.

For more information on MEDICAL FAIR ASIA Digital Edition, please visit www.medicalfair-asia.com


About Messe Düsseldorf Asia

Messe Düsseldorf Asia is a subsidiary of Messe Düsseldorf in Germany, one of the world’s leading trade fair organisers responsible for organising more than 20 global No. 1 exhibitions held in Düsseldorf, Germany; across various sectors such medical and healthcare, workplace safety, security and health, packaging, printing, plastics, rubber, wire and tube, and wine and spirits, With extensive expertise in organising trade fairs in Southeast Asia, Messe Düsseldorf Asia has developed a portfolio of well-established trade fairs in the region since 1995. For more information, visit http://mda.messe-dusseldorf.com/

Previous Post

CPhI Annual Report 2020 Part 1: 2025 will see cell and gene therapy capacity shortages in the USA and 10+ mAb approvals in China

Next Post

New Liquid Chromatography-Mass Spectrometry Workstream offers Comprehensive Solution for Toxicology

Related Posts

Pharma Advancement Banner
Press Statements

Welcome to the Inaugural Operationalize: Expanded Access Programs Summit West

27th June 2025
Avadel Pharmaceuticals Receives
Drug Development

Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

9th June 2025
ACHEMA
Middle East and South Asia

ACHEMA Middle East to Debut in Riyadh in 2026 Trade Show

9th May 2025
Press Statements

APM Steam Highlights Comprehensive HVAC Insulation Services for Biopharmaceutical and Pharmaceutical Facilities

19th April 2025
Americas

Thermo Fisher to acquire Solventum’s Purification & Filtration business for US$4.1bn

4th March 2025
Drug Development

Celonic Group Signs Long-Term Multi-Year Manufacturing Service Agreement with LINDIS Biotech for the Commercial Supply of Catumaxomab

4th March 2025
Next Post
New Liquid Chromatography-Mass Spectrometry Workstream offers Comprehensive Solution for Toxicology

New Liquid Chromatography-Mass Spectrometry Workstream offers Comprehensive Solution for Toxicology

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In